About
Dan Alminana is Elysium Health's Co-Founder and Chief Operating Officer. He helped build the company with CEO Eric Marcotulli and Chief Scientist Leonard Guarente, PhD, pairing finance and operating experience with MIT aging-biology roots. Before Elysium, Alminana worked at Deloitte, Citi Smith Barney, and JP Morgan Securities, where his bio credits him with launching the bank's Silicon Valley venture-capital coverage unit for healthcare and technology startups across the US, Asia, and Europe.
What to Know
Signature approach
Alminana's contribution is business operations: helping Elysium run the consumer-commerce, lab-partner, support, and research-enrollment surfaces that sit around products like Index. His finance background matters because Elysium is not a clinic; it is a DTC health company trying to keep product, study, regulatory, and customer operations aligned.
What sets them apart
- Finance-to-operations path. Deloitte, Citi Smith Barney, and JP Morgan Securities gave him experience around venture-backed healthcare and technology companies.
- Long founder tenure. He has been with Elysium since its 2014 founding.
- Operator counterpart to the science team. His role complements Guarente, Ryan Dellinger, and Dayle Sampson by keeping the company execution layer coherent.
Affiliations
Other specialists at Elysium Health
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.